Showing results (81-90 of 322) with videos related to
Sort By:
Pageof 33
European Urology Focus|June 5, 2019
The International Penile Advanced Cancer Trial (InPACT): Rationale and Current StatusDaniel J Canter, Steve Nicholson, Nick Watkin, et al.Stroke (Hoboken, N.J.)|January 23, 2026
Influence of Comorbidity on Endovascular Thrombectomy Outcomes for Medium-Vessel Occlusion Stroke: A Nationwide Prospective Observational StudyEmma Hall, Johan Wassélius, Mats Pihlsgård, et al.International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivationChris Parker, Padraig Warde, Andy Norman, et al.Journal of Cancer|July 14, 2011
Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER TrialDarren R Feldman, Robert Huddart, Emma Hall, et al.Clinical Neuroradiology|September 22, 2025
Balloon Guide Catheter Use and Outcomes After Endovascular Thrombectomy for Ischemic Stroke Due to Large Vessel OcclusionsBjörn M Hansen, Emma Hall, Alex Szolics, et al.Clinical Neuroradiology|March 31, 2025
Outcomes After Thrombectomy for Primary and Secondary Medium Vessel MCA Occlusions: a Nationwide Registry StudyBjörn M Hansen, Emma Hall, Birgitta Ramgren, et al.Neuroradiology|July 14, 2026
Endovascular thrombectomy for subterminal internal carotid artery occlusions: clinical and radiological heterogeneity in a nationwide registryEmma Hall, Björn M Hansen, Alex Szolics, et al.European Urology Oncology|September 7, 2021
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)John N Staffurth, Joanne S Haviland, Anna Wilkins, et al.BJU International|November 1, 2012
Diethylstilbestrol in castration-resistant prostate cancerAnna Wilkins, Mehdi Shahidi, Chris Parker, et al.BMJ Open|January 1, 2021
Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidanceShaista Hafeez, Amanda Webster, Vibeke N Hansen, et al.Pageof 33